BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9742770)

  • 1. [Losartan--a nonpeptide antagonist of angiotensin-II receptors in the treatment of heart failure].
    Berezin AE; Fushteĭ IM
    Klin Med (Mosk); 1998; 76(7):12-5. PubMed ID: 9742770
    [No Abstract]   [Full Text] [Related]  

  • 2. [The outlook for the use of the nonpeptide angiotensin II-receptor antagonist losartan in treating heart failure].
    Dunaev VV; Berezin AE
    Eksp Klin Farmakol; 1999; 62(4):77-80. PubMed ID: 10513345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
    McMurray JJ
    J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):89-92. PubMed ID: 11881104
    [No Abstract]   [Full Text] [Related]  

  • 5. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M
    Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 7. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors].
    Berger D
    Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712087
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC; MacDonald TM
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiotensin therapy: new perspectives.
    Ramasubbu K; Mann DL; Deswal A
    Cardiol Clin; 2007 Nov; 25(4):573-80; vi-vii. PubMed ID: 18063161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the renin angiotensin system in heart failure: the potential place of angiotensin II receptor blockers.
    van Veldhuisen DJ; Voors AA
    Eur Heart J; 2000 Jan; 21(1):14-6. PubMed ID: 10610738
    [No Abstract]   [Full Text] [Related]  

  • 11. AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions.
    Willenheimer R; Dahlöf B; Rydberg E; Erhardt L
    Eur Heart J; 1999 Jul; 20(14):997-1008. PubMed ID: 10381851
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA; Berezin AE
    Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW; Berent R; Eber B
    Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
    [No Abstract]   [Full Text] [Related]  

  • 14. What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?
    Dickstein K
    Am Heart J; 2003 May; 145(5):754-7. PubMed ID: 12766730
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure.
    McKelvie R
    Clin Evid; 2002 Jun; (7):57-78. PubMed ID: 12230638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Angiotensin II antagonists: a promising pathway].
    Cohen-Solal A
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():10-1, 15. PubMed ID: 10949700
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antihypertensive effects of angiotensin II receptor antagonists.
    Burnier M; Brunner HR
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S278-82. PubMed ID: 10201883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can Sartane help a failing heart? AT1-receptor antagonists in cardiac insufficiency].
    Düsing R
    Pharm Unserer Zeit; 2001; 30(4):314-20. PubMed ID: 11499257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.